REQUEST A DEMO
Total
USD $0.00
Search more companies

Libra Bioscience Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Libra Bioscience Private Limited Profile Updated: January 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Libra Bioscience Private Limited is an unlisted company, incorporated on 18/02/2011. It has its registered office in the State of Madhya Pradesh, India. Company's corporate identification number (CIN) is U24230MP2011PTC025419 and registration number is 025419. The company is a trade, manufacturing company, it is engaged in wholesale trading, chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
412, Apollo Tower 2, M.G.Road
Indore; Madhya Pradesh; Postal Code: 452001

Contact Details: Purchase the Libra Bioscience Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Libra Bioscience Private Limited report to view the information.
Financial Auditors:
Purchase the Libra Bioscience Private Limited report to view the information.
Incorporation Date:
February 18, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Libra Bioscience Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
55.79%
Total operating revenue
55.57%
Operating profit (EBIT)
42.17%
EBITDA
36.6%
Net Profit (Loss) for the Period
65.76%
Total Assets
9.98%
Total Equity
28.16%
Operating Profit Margin (ROS)
-0.34%
Net Profit Margin
0.1%
Return on Equity (ROE)
4.98%
Debt/Equity
-75.95%
Quick Ratio
-0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?